Harnessing clinical datasets from the repository of electronic health records for research and medical intelligence has become the norm of the 21st century. Clinical datasets present a great opportunity for medical researchers and data analysts to perform cohort selections and data linkages to support better informed clinical decision-making and evidence-based medicine. This paper utilized Logical Observation Identifiers Names and Codes (LOINC®) encoding methodology to encode the biochemistry tests in the anonymized biochemistry dataset obtained from the Health Informatics Centre (HIC) at the University of Dundee. Preliminary results indicated that the encoded dataset was flexible in supporting statistical analysis and data mining techniques. Moreover, the results indicated that the LOINC codes cover most of the biochemistry tests used in National Health Service (NHS) Tayside, Scotland.
INTRODUCTION
Clinical datasets are discrete uniform set of health data elements that support healthcare research and clinical decision-making at the point of care. Clinical datasets provide an excellent environment in which combined analyses of both structured and unstructured datasets can prove fruitful and useful (Bonney, 2013; Lamont, 2006) . Clinical datasets are often viewed as minimum care assurance datasets (Wirtschafter & Mesel, 1976) or minimum clinical datasets (MCDs) for care provision (SvenssonRanallo, Adam, & Sainfort, 2011) . Citing Berwick's (2002) framework of quality, Svensson-Ranallo et al. (2011) defined MCDs as the minimum datasets "developed for, used by, and targeting actions that occur at the 'microsystem' level of healthcare" (p. 54). More specifically, minimum clinical datasets provide the necessary information needed to support clinical care for a particular domain of intervention.
Clinical datasets are usually extracted from electronic health records (EHRs) (Bonney, 2013) . The recent expansion of very large biological collections for exploring genomic and other biomarker determinants of disease susceptibility and treatment response has generated intense interest in augmenting the availability of clinical datasets derived from EHRs. The massive availability of clinical datasets in the repository of EHRs, therefore, presents a great opportunity for medical researchers and data analysts to discover hidden knowledge from medical records. The discovered knowledge has the potential to support early disease detection, improve population health outcomes, and facilitate the development of clinical decision support systems (Bonney, 2011; Razavi, Gill, Åhlfeldt, & Shahsavar, 2005) .
The availability of clinical datasets in EHRs also makes it easier for researchers and data analysts to perform cohort selections and data linkages to support epidemiological study designs such as cohort and case control studies. These studies require minimum clinical datasets to answer research questions (Abhyankar, Demner-Fushman, & McDonald, 2012; Sanders et al., 2012; SvenssonRanallo et al., 2011; van Vlymen & de Lusignan, 2005) . However, raw datasets extracted from EHRs are voluminous and heterogeneous and do not often incorporate enough data standardization in their design and thus require further pre-processing techniques from the part of the researchers in analyzing the datasets (Abhyankar et al., 2012; Cios & Moore, 2002) . This paper utilizes a heuristic LOINC encoding methodology to encode the biochemistry tests in the anonymized biochemistry dataset obtained from the Health informatics Centre (HIC) at the University of Dundee. The paper is divided into three parts. In the first part, the focus is on related studies and the overview of the HIC-held biochemistry dataset. The second part discusses the methodology of encoding the HIC-held biochemistry datasets with the LOINC controlled vocabulary. In the third part, the focus is on the results and the research implications of the study.
RELATED STUDIES
Several studies have been conducted in the literature to assess the feasibility and applicability of preprocessing routinely collected clinical data (Bonney, 2013; Lee, Lau, & Quan, 2010; Lin & Haug, 2006; Svensson-Ranallo et al., 2011; van Vlymen, J., & de Lusignan, 2005) . Prominent amongst these studies is the work of SvenssonRanallo et al. (2011) , who postulated the development of high quality minimum clinical datasets (MCDs) for collecting data during the routine process of care. Svensson-Ranallo et al.'s (2011) streamlined methodology involved the identification of "a bottom-up, multi-modal approach in which data elements identified in both the literature and patient charts are critically evaluated by domain experts through a formal harmonization and iterative process" (p. 56). The harmonization and iterative process is an essential step in ensuring that any agreed uniform set of data elements, by the domain experts, produces high quality outcomes and support optimal clinical decision-making at the point of care.
In a related study, van Vlymen and de Lusignan, S. (2005) proposed a novice approach of using metadata to encode the structural components of data elements in a "controlled vocabulary to name the core clinical concepts within the metadata" (p. 281). van Vlymen and de Lusignan (2005) argued that the routine use of a metadata system has the potential to improve the reliability of processing large primary care datasets. Attractive and impressive as the approach presents, van Vlymen and de Lusignan (2005) acknowledged the limitation of the study by asserting that the metadata system cannot as yet be machine processed. This limitation is crucial when it comes to preprocessing clinical datasets for medical research purposes. Clinical datasets need to be machine-processable to support statistical analysis and data mining techniques by researchers and data analysts.
In another study, Lin and Haug (2006) proposed a data preparation framework for converting raw clinical datasets to a format that is acceptable to model machine learning algorithms. The approach utilized policies and rules generated "according to the statistical characteristics of the data, the metadata that characterizes the host information systems and medical knowledge" (Lin & Haug, 2006, p. 489) . In other words, the framework categorizes clinical information into three main areas (i.e., data, metadata, and medical knowledge) and applies rules and policies in accordance with the information. According to Lin and Haug (2006) , the conversion or categorization of the clinical information is necessary to reduce the manual work involved in data preprocessing techniques by researchers.
The data preparation framework by Lin and Haug (2006) and the use of the metadata system by van Vlymen and de Lusignan (2005) did not focus on the standardization of the clinical datasets for medical research purposes. Moreover, the streamlined methodology by Svensson-Ranallo et al. (2011) focused solely on the best practices of collecting and harmonizing clinical datasets for optimal clinical decision-making. This study, however, encodes the biochemistry test elements of the anonymized HIC-held biochemistry dataset with LOINC codes to support statistical analysis of the dataset by researchers and data analysts.
HIC-HELD BIOCHEMISTRY DATASET
The Health Informatics Centre (HIC) at the University of Dundee operates as a clinical research data portal for healthcare data acquired through the National Health Service (NHS) activity in the Tayside region of Scotland, which covers a population of approximately 400,000. Clinical healthcare data from a comprehensive array of clinical domains are anonymized, extracted, maintained, published, and governed by HIC. The HIC-held biochemistry dataset comprises of the entire historical biochemistry data obtained from the centralized blood sciences laboratory in Tayside. The dataset used for this study is a subset of data released on June 2011 as part of the Genetics of Diabetes Audit and Research in Tayside, Scotland (GoDARTS) dataset. GoDARTS comprises of a very large biological resource for the study of type 2 diabetes and constitutes a major component of the Tayside Bioresource (University of Dundee, n.d.). The number of extracted records for the June 2011 release was made up of 8,936,095 data elements from 17,562 unique GoDARTS' participants.
METHODS
This study utilizes a heuristic LOINC encoding methodology to encode the laboratory tests in the anonymized HIC-held biochemistry dataset. The methodology is in alignment with the best practice guidelines published by the American Health Information Management Association (AHIMA). AHIMA (2011) specified six basic steps for mapping data contained in the repository of EHRs. These six steps involved: 1) developing a business case; 2) defining a specific use case; 3) developing heuristics/rules for implementation; 4) planning a pilot phase to test the rules; 5) developing full content with periodic testing; and 6) communicating with source and target data owners. As part of this study, five of the best practice guidelines (i.e., steps 1-5) were implemented. One of the objectives for the future work of this study is to address the last step (i.e., step 6) in the AHIMA's (2011) best practice guidelines.
Other researchers have acknowledged the importance of the data mapping guidelines developed by AHIMA. For example, Abhyankar et al. (2012) used similar methodology in standardizing the laboratory tests contained in EMR databases for secondary data use purposes. Although Abhyankar et al. (2012) developed their own mapping rules and asserted that the AHIMA's (2011) work is not based on direct mapping exercise, they acknowledged that they were pleased to find out that their mapping guidelines conformed to the AHIMA best practice guidelines. This study also utilized some of the key mapping rules developed by Abhyankar et al. (2012) .
Logical Observation Identifiers Names and Codes (LOINC®) is an open standard being developed by the Regenstrief Institute and made available free to the public. LOINC is a "universal code system for identifying laboratory and clinical observations that facilitates exchange and pooling of results for clinical care, research, outcomes management, and many other purposes" (Vreeman, Chiaravalloti, Hook, & McDonald, 2012, p. 668) . Specifically, LOINC is the lingua franca of exchanging laboratory and clinical observations. LOINC has "standardized terms for observations and measurements that enable exchange and aggregation of electronic health data from many independent systems" (LOINC, 2013). It is, therefore, not very surprising that the interoperability specifications for electronic laboratory reporting specify the need to use LOINC codes in laboratory information systems (Fidahussein, Friedlin, & Grannis, 2011; Lin, Vreeman, & Huff, 2011; McDonald et al., 2003; Vreeman et al., 2012) . The encoding of the laboratory tests in the anonymized HIC-held biochemistry dataset with LOINC codes was facilitated by the use of the Regenstrief LOINC Mapping Assistant (RELMA) (RELMA, 2013) . RELMA makes it easier to search the LOINC database, associate and/or map local terms to the universal LOINC codes (Abhyankar et al., 2012; Khan et al., 2006; Vreeman et al., 2012; Wilson & Scichilone, 2011) . In using the RELMA Version 6.2, the Mapping module was used for searching through the LOINC database to identify the appropriate LOINC codes to be mapped to the HIC-held biochemistry test codes. The approach was similar to the study carried out by Abhyankar et al. (2012) with the exception that the Lab Auto-Mapper module of RELMA was not used for this study.
RESULTS
The HIC-held biochemistry dataset contained 168 unique local test codes. A few of the test codes were found to be redundant as they represented the same test concept, but from different laboratory systems over time. The encoding process utilized the three mapping classifications used in the study by Abhyankar et al. (2012) : (a) Exact match (i.e., when the test code had the same analyte name, unit of measure and given or inferred specimen type; (b) Ambiguous but likely match (i.e., when the tests were mapped to the exact analyte but there were issues with the likely specimen type and/or unit of measure; and (c) No match (i.e., when the test codes were too vague; and there were no available LOINC codes). Table 1 shows the overall results of each of the three classifications.
The encoding process provided a reliable platform to map redundant local HIC test codes to unique LOINC codes. The encoding results indicated that 145 tests, representing 86.31% of the HIC-held biochemistry test codes, were correctly mapped to LOINC. Whereas 7.74% of the test codes were classified as ambiguous but likely match, approximately 5.95% of the test codes had no exact match in the LOINC codes. The difficulty in finding the exact LOINC code for some of the tests could be attributed to the fact that there were missing variable units of measure and/or specimen types in the dataset.
There were also some instances whereby two different test descriptions were represented with the same test code. For example, both Vitamin D and 25-Hydroxyvitamin D was represented with a single test code (i.e., VITD) within the biochemistry dataset. This problem in the dataset could have been easily avoided using the LOINC codes 35365-6 and 68438-1 for Vitamin D and 25-Hydroxyvitamin D respectively. Table 2 shows examples of multiple HIC-held biochemistry test codes mapped to a single LOINC code.
The longitudinal nature of the HIC-held biochemistry dataset also contributed to the complexity in encoding the local test codes with LOINC. Most of the test codes were received through different laboratory systems and the measurement units were changed over time with different laboratory methods and reference ranges. Consequently, the initialization of the encoding process resulted in iterative and time-consuming efforts. Abhyankar et al. (2012) also encountered similar difficulty by noting that the mapping process is labour intensive, but only have to be done once.
RESEARCH IMPLICATIONS
The encoding of the biochemistry dataset with LOINC enables easier manipulation of the dataset with data mining algorithms and other statistical software packages such as STATA, SPSS, SAS and (Lee et al., 2010) . Moreover, the idea of encoding the biochemistry tests with LOINC codes is to support future use of the data elements in structured instrument development for research purposes (Svensson-Ranallo et al., 2011) . The result also indicated that the LOINC codes cover most of the biochemistry tests used in NHS Tayside, Scotland. This finding suggests that the LOINC mapping method has the potential to be used by HIC to map all the Tayside laboratory tests to LOINC. This could be applied to HIC-held datasets such as Haematology, Immunology, Microbiology, and Virology.
It is worth mentioning that the methodology used in this study is important not only for generating researchable data from routine NHS healthcare data, but also for linking researchable data to very large genomic resources for translational research. The approach enhances the ability to combine biochemistry datasets from potentially disparate sources, such as between healthcare regions, or even across national boundaries. This is a vital prerequisite for generating the very large datasets required for genomic research using healthcare records.
CONCLUSIONS
This paper has discussed the importance of encoding clinical datasets with LOINC codes. The preliminary results indicated that the encoding is necessary in supporting statistical analysis and data mining techniques. This is necessary to ensure that the biochemistry dataset is not left in its heterogeneous state with little or no meaning in statistical analysis and clinical data exchange. Standardizing the data elements of the HIC-held biochemistry dataset with controlled vocabulary such as LOINC ensures that the dataset is not only valid for research purposes but also is interoperable with other healthcare systems that might further use the dataset for clinical and administrative purposes.
Preprocessing clinical datasets still remains a huge challenge in the medical domain. However, data preprocessing and transformation are required before one can apply meaningful statistical methods and data mining techniques to clinical datasets (Lin & Haug, 2006) . Data preprocessing is important because quality decisions must be based on quality data (Han, Kamber, & Pei, 2011; Razavi et al., 2005) . Thus, the acquisition of quality data, through data preprocessing, will lead to high quality healthcare delivery and better clinical knowledge. High quality data is a primary factor for successful knowledge discovery from clinical datasets.
For the next step, the goal is not only to fulfil all the requirements for the AHIMA's (2011) best practice guidelines, but also to replicate the methodology to other legacy laboratory test codes currently used in the HIC-held datasets. These would involve (a) performing a final quality assurance test on the identified LOINC codes for the biochemistry dataset, resolving any of the unmapped test codes, and seeking clarity and additional documentation from data owners for the unmapped test codes; (b) communicating and validating the identified LOINC codes with a qualified third-party (e.g., NHS Tayside); and (c) replicating the methodology for other legacy laboratory test codes for haematology, immunology, microbiology, and virology. Completing this future work will ensure that all the HIC-held laboratory test codes are standardized to support medical research and semantic interoperability.
